MEK inhibitor
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for MEK inhibitor, covering 2017-11-13 to 2025-07-03. Get the full timeline:
Most recent: Clinical Trial Update: Early Phase Study Evaluating MEK and MDM2 Inhibition in Patients With NF1 and MPNST [Phase 1, Phase 2]